BioWorld

Jan. 9, 2002

View Archived Issues

DeCode Adding Chemistry Via $83.6M MediChem Acquisition

Calling the move not only logical, but necessary, DeCode Genetics Inc. said it is buying MediChem Life Sciences Inc. in a stock swap worth about $83.6 million. Read More

Pharmacyclics: Xcytrin Works In Lung-Brain Metastasis Group

Read More

Iowa University, IntronnJoin To Correct Cystic Fibrosis Mutant Gene In Customized Mouse Mimic

Read More

IDEC Hits Manufacturing Snag With Zevalin; Trials Not Needed

Read More

Other News To Note

Read More

Signature Adding To Oncology Portfolio Via PrimeCyte Purchase

Read More

Enzon, Inhale Enter Broad Deal On Pegylation, Licensing, Lawsuit

Read More

Maxygen Partners With Celltech To Work On Antibody Programs

Read More

3-D Pharma In-Licenses Drug From GSK Through Stock Deal

Read More